StockStory.org on MSN

NEOG Q4 deep dive: Operational improvements and new leadership drive upbeat outlook

Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results , but sales fell by 2.8% year on year to $224.7 million ...